Related Experiment Videos
ASH position paper: hypertension in pregnancy
Marshall D Lindheimer1, Sandra J Taler, F Gary Cunningham
1Department of Obstetrics & Gynecology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA. mlevine@ash-us.org
Journal of Clinical Hypertension (Greenwich, Conn.)
|July 21, 2009
Summary
Hypertension in pregnancy, particularly preeclampsia, affects 5-7% of pregnancies, causing significant maternal and fetal harm. This paper reviews its classification, prediction, prevention, and management, including eclampsia treatment.
Area of Science:
- Cardiovascular Medicine
- Obstetrics & Gynecology
- Nephrology
Background:
- Hypertension complicates 5% to 7% of all pregnancies.
- Preeclampsia, a subset of hypertensive disorders in pregnancy, is linked to substantial maternal and fetal morbidity and future cardiovascular and metabolic disease.
- This position paper addresses the clinical spectrum of pregnancy-related hypertension.
Purpose of the Study:
- To summarize the clinical spectrum of hypertension in pregnancy, with a focus on preeclampsia.
- To review recent research on the etiology of preeclampsia.
- To provide guidance on classification, prediction, prevention, and management strategies for hypertensive disorders in pregnancy.
Main Methods:
- This is a position paper summarizing existing knowledge and guidelines.
- It incorporates solicited review advice from the American College of Obstetricians and Gynecologists.
- The paper reviews recent research breakthroughs and clinical practices.
Main Results:
- Hypertension in pregnancy, especially preeclampsia, presents a significant clinical challenge.
- Current understanding of etiology is evolving.
- Effective management strategies exist for prevention and treatment.
Conclusions:
- Preeclampsia requires careful classification, prediction, and management.
- Intravenous magnesium sulfate is highlighted for eclampsia prevention and treatment.
- This paper provides a comprehensive overview for clinicians and researchers.
Related Concept Videos
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:23Hypertension V: Nursing Management
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...